Home Ingredients Human Milk Oligosaccharides (HMOs)
Gut HealthImmune Support

Human Milk Oligosaccharides (HMOs)

Evidence Level
Moderate
3 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Human milk oligosaccharides (HMOs) are complex carbohydrates that are the third most abundant solid component of human breast milk, after lactose and lipids. More than 150 distinct HMO structures have been identified, with 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) among the most studied. HMOs are not digested by the infant; instead, they reach the colon largely intact, where they feed beneficial bacteria such as Bifidobacterium infantis. In laboratory studies they can also bind certain pathogens, a proposed mechanism that has not been tested in people taking an HMO supplement. Modern supplements use bioidentical HMOs produced by microbial fermentation, allowing children and adults outside of infancy to access these compounds. Human research is still limited. The one adult trial cited here was a randomized, placebo-controlled study in 100 healthy adults that ran for 2 weeks and measured gut bacteria. Most other published work is in infants, and the cognitive findings come from an observational study of breast milk rather than from a supplement trial.

Studied Dose The adult trial cited on this page used up to 20 g/day of 2'-FL and/or LNnT for 2 weeks; infant formulas typically supply 0.2-1.5 g/L. Consumer supplement servings are generally much smaller than the amount used in that trial, so its results do not automatically carry over to them.
Active Compound Fucosylated HMOs (2'-fucosyllactose, 3-fucosyllactose), sialylated HMOs (3'-sialyllactose, 6'-sialyllactose), and core HMOs (lacto-N-neotetraose, lacto-N-tetraose).

Benefits

Supports a Healthy Gut Microbiome

In a randomized, double-blind, placebo-controlled trial of 100 healthy adults, taking 2'-FL and/or LNnT for 2 weeks raised the share of Bifidobacterium and Actinobacteria in stool and lowered Firmicutes and Proteobacteria. The study measured bacteria and tolerability only; whether that shift makes people feel better or improves any health outcome was not tested.

Supported by Trial 1

Promotes Immune Resilience

In laboratory studies HMOs can bind some pathogens and interact with immune cells, and reviews of infant formula research report gut microbiota and biomarker patterns closer to those of breastfed infants. None of the studies cited here measured immune outcomes, infections, or gut barrier function in adults taking an HMO supplement.

Supported by Trial 3, Trial 2

Cognition: Studied Only in Breastfed Infants

In an observational study of 50 mother-infant pairs, the amount of 2'-FL naturally present in breast milk at 1 month was linked to higher cognitive scores at 24 months. That is an association in breastfed infants, not a supplement trial, and the same study found no association for 2'-FL measured at 6 months. Nothing cited here shows that an HMO supplement affects thinking or memory in children or adults.

Supported by Trial 2

Helps Maintain Gut Barrier Integrity

Gut bacteria ferment HMOs into short-chain fatty acids, which in laboratory studies feed the cells lining the colon and support the junctions between them. Gut barrier measurements were not reported in any of the human studies cited on this page.

Supported by Trial 1, Trial 3

Effect on Bowel Habits Is Not Established

Gut bacteria ferment HMOs into short-chain fatty acids, but no study cited on this page tested bowel habits. The 2-week adult trial reported only safety and tolerability, and no cited study examined this question in children.

Supported by Trial 1, Trial 3

Mechanism of action

1

Selective Bifidogenic Activity

HMOs are preferentially metabolized by Bifidobacterium infantis and other beneficial strains carrying specific glycoside hydrolases, which is the likely reason Bifidobacterium levels rose over the 2 weeks of the adult trial. How quickly this happens was not established by the studies cited here.

2

Decoy Receptor Function

Fucosylated and sialylated HMOs resemble glycans on intestinal cell surfaces, and in laboratory studies they can bind pathogens such as norovirus and certain E. coli strains before those microbes attach to cells. This has not been shown to reduce infections in people taking an HMO supplement.

3

Short-Chain Fatty Acid Production

Microbial fermentation of HMOs produces acetate, propionate, and butyrate, which lower the acidity of the colon and feed the cells lining it. Body-wide anti-inflammatory effects are a laboratory-based idea and were not measured in the human studies cited here.

4

Immune Modulation

In laboratory work HMOs interact directly with immune cells and change cytokine production. This is a proposed mechanism, and immune markers were not measured in the human studies cited on this page.

Clinical trials

1
2'-FL and LNnT in Healthy Adults

Randomized, double-blind, placebo-controlled, parallel-arm trial over 2 weeks

100 healthy adults receiving 2'-FL, LNnT, or a mix versus placebo

Doses up to 20 g/day increased the relative abundance of Bifidobacterium and Actinobacteria and reduced Firmicutes and Proteobacteria, and the HMOs were safe and well tolerated. The trial lasted only 2 weeks and measured gut bacteria and tolerance, not digestive symptoms, immunity, or any other health outcome.

2
Breast Milk 2'-FL and Infant Cognition (Observational, No Supplement)

Observational cohort study, not a clinical trial. No supplement was given; naturally occurring HMO levels in breast milk were measured

50 Hispanic mother-infant pairs, with breast milk sampled at 1 and 6 months and infant cognition assessed at 24 months

2'-fucosyllactose in breast milk at 1 month was associated with higher cognitive scores at 24 months, but there was no association for 2'-FL measured at 6 months. Because this is an observational study in breastfed infants, it cannot show that an HMO supplement improves cognition at any age.

3
2'-FL and LNnT in Infant Formula

Review of multiple randomized, controlled growth and tolerance studies in formula-fed infants

Healthy infants randomized to HMO-supplemented formula or control formula

HMO-supplemented infant formulas supported normal growth and tolerance and were associated with stool microbiota and biomarker patterns closer to those of breastfed infants compared with standard formulas. This is a review of infant formula research, so it says nothing about what an HMO supplement does in older children or adults.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated; mild gas, bloating, or loose stools may occur initially.
These effects are commonly reported to settle with continued use, though the cited research did not track how long they last.
Very high intakes may cause more pronounced osmotic effects in sensitive users.
Rare reports of mild abdominal discomfort at high doses.
No serious adverse events were reported in the 2-week adult trial at doses up to 20 g/day. Longer-term safety in adults was not assessed by the research cited here.

Important Drug interactions

No drug interactions have been documented, but interactions have not been formally studied either.
In theory, changing gut bacteria could affect medicines that depend on gut microbes, but this has not been tested with HMOs.
Any effect on how the gut recovers after a course of antibiotics is unknown; it has not been studied.
Consult a clinician if combining with immunosuppressive therapy.

More Gut Health Ingredients

Gut Health
Pancrelipase / Pancreatin
Pancrelipase (also called pancreatin) is a standardized blend of three primary pancreatic…
Gut Health
Sunfiber® (Partially Hydrolyzed Guar Gum)
Sunfiber® is the original and most extensively clinically-studied partially hydrolyzed gua…
Gut Health
Peppermint (Mentha × piperita)
Peppermint is a hybrid mint (Mentha aquatica × Mentha spicata) whose leaves and extracted…
Gut Health
PepZinGI® (Zinc-Carnosine for Gut Lining)
PepZinGI® (NutriScience Innovations) is a unique chelate of zinc and L-carnosine in a 1:1…

Explore Other Ingredients

Muscle & Recovery
Bromelain
Bromelain is a group of protein-digesting enzymes extracted from pineapple stems, used in…
Muscle & Recovery
L-Glutamine
L-glutamine is the most abundant amino acid in the body and the primary metabolic fuel for…
Metabolic Health
Inulin
Inulin is a soluble prebiotic fiber found naturally in chicory root, agave, and many veget…

Frequently asked questions about Human Milk Oligosaccharides (HMOs)

What are human milk oligosaccharides (HMOs)?

HMOs are special prebiotic fibers that are naturally the third most abundant component of human breast milk. They are not digested by the baby but feed beneficial gut bacteria, especially bifidobacteria. Researchers believe they also help shape the developing immune system, though that comes from laboratory and infant formula research rather than from supplement trials. Supplement versions like 2'-FL are made by fermentation.

What are HMOs used for in supplements?

Beyond infant formula, HMOs such as 2'-fucosyllactose are sold as adult prebiotics. The one adult trial cited here showed they raise Bifidobacterium levels over 2 weeks. Benefits for the gut barrier or the immune system in adults have not been demonstrated.

How much HMO should I take?

Adult supplements usually provide about 1 to 5 grams per day of a single HMO such as 2'-FL, which is below the doses of up to 20 grams per day used in the adult trial. Follow the product labeling. They were well tolerated in that trial.

Are HMOs safe?

Fermentation-derived HMOs used in formula and supplements have regulatory safety clearance and were well tolerated in a 2-week trial in 100 healthy adults and in infant formula studies. Long-term safety data in adults are limited. Larger amounts may cause mild, temporary digestive changes as the microbiome adjusts.

What is Human Milk Oligosaccharides?

Human milk oligosaccharides (HMOs) are complex carbohydrates that are the third most abundant solid component of human breast milk, after lactose and lipids. More than 150 distinct HMO structures have been identified, with 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) among the most studied.

What is Human Milk Oligosaccharides used for?

Human Milk Oligosaccharides is researched primarily for Gut Health and Immune Support. In a randomized, double-blind, placebo-controlled trial of 100 healthy adults, taking 2'-FL and/or LNnT for 2 weeks raised the share of Bifidobacterium and Actinobacteria in stool and lowered Firmicutes and Proteobacteria.

What is the recommended dosage of Human Milk Oligosaccharides?

The clinically studied dose is The adult trial cited on this page used up to 20 g/day of 2'-FL and/or LNnT for 2 weeks; infant formulas typically supply 0.2-1.5 g/L. Always follow the product label and check with a healthcare provider for personal advice.

Is Human Milk Oligosaccharides safe, and does it have side effects?

For most healthy adults, Human Milk Oligosaccharides is well tolerated at studied doses. Reported effects can include: Generally well tolerated; mild gas, bloating, or loose stools may occur initially. These effects are commonly reported to settle with continued use, though the cited research did not track how long they last. It may also interact with some medications. Human Milk Oligosaccharides is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Human Milk Oligosaccharides interact with any medications?

Possible interactions include: No drug interactions have been documented, but interactions have not been formally studied either. In theory, changing gut bacteria could affect medicines that depend on gut microbes, but this has not been tested with HMOs. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Human Milk Oligosaccharides?

NutraSmarts rates the evidence for Human Milk Oligosaccharides as Moderate (3 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Elison E, Vigsnaes LK, Rindom Krogsgaard L, et al. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. British Journal of Nutrition. 2016;Br J Nutr. 2016 Oct;116(8):1356-1368..PubMedUsed to support: Two-week randomized, double-blind, placebo-controlled trial in 100 healthy adults; doses up to 20 g/day of 2'-FL and LNnT were safe and well tolerated and increased the relative abundance of Bifidobacterium and Actinobacteria in stool while reducing Firmicutes and Proteobacteria.
  2. Berger PK, Plows JF, Jones RB, et al. Human milk oligosaccharide 2'-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers. PLoS One. 2020;PLoS One. 2020 Feb 11;15(2):e0228323..PubMedUsed to support: Observational cohort of 50 mother-infant pairs. 2'-fucosyllactose measured in breast milk at 1 month was associated with higher cognitive scores at 24 months, with no association found for 2'-FL at 6 months. No supplement was given and no adults were studied.
  3. Berger PK, Bansal R, Sawardekar S, et al. Human Milk Oligosaccharides and Infant Neurodevelopment: A Narrative Review. Nutrients. 2023;Nutrients. 2023 Jan 30;15(3):719..PubMedUsed to support: Narrative review of infant neurodevelopment research. It is a review rather than a clinical trial and is not evidence that HMO supplements affect cognition in children or adults.
  4. Vandenplas Y, Berger B, Carnielli VP, et al. Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula. Nutrients. 2018;Nutrients. 2018 Aug 24;10(9):1161..PubMedUsed to support: Review of HMO biology and randomized infant formula studies reporting normal growth and gut microbiota and biomarker patterns closer to breastfed infants. This is infant formula evidence only and does not apply to adult supplement use.